Financial Star

S&P 500

6,643.70 (+0.59%)

Dow 30

46,247.29 (+0.65%)

Nasdaq

22,484.07 (+0.44%)

Russell 2000

2,434.32 (+0.97%)

Crude Oil

65.19 (+0.32%)

Gold

3,789.80 (+0.50%)

Silver

46.37 (+2.77%)

EUR/USD

1.1708 (+0.35%)

10-Yr Bond

4.1870 (+0.36%)

GBP/USD

1.3402 (+0.44%)

USD/JPY

149.4540 (-0.20%)

Bitcoin USD

109,649.58 (+0.47%)

XRP USD

2.78 (+1.43%)

FTSE 100

9,284.83 (+0.77%)

Nikkei 225

45,354.99 (-0.87%)

Stocks

Symbol	Price	Change	%Change
BQ	9.92	6.994	239.0294%
YCBD	1.418	0.794	127.2436%
GIGGW	0.5	0.251	100.8032%
ENTA	15.16	7.26	91.8987%
AUUDW	0.0274	0.0128	87.6712%

Symbol	Price	Change	%Change
MLTX	6.245	-55.745	-89.9258%
KALA	2.045	-17.005	-89.2651%
IOBT	0.3651	-1.2149	-76.8924%
OUSTW	0.0018	-0.0047	-72.3077%
MTEKW	0.22	-0.566	-72.0102%

Symbol	Price	Change	%Change
TLRY	1.85	0.7	60.8696%
YCBD	1.418	0.794	127.2436%
NVDA	181.8768	3.6868	2.069%
SNAP	8.395	0.125	1.5115%
SOXS	5.315	0.005	0.0942%

Real Estate News

Spotify ( SPOT ) Laps the Stock Market: Here's Why

Spotify (SPOT) closed at $728.47 in the latest trading session, marking a +1.67% move from the prior day.

Opendoor Names a New CEO. Here's What It Could Mean for Investors.

Opendoor's stock has taken off like a rocket ship, leaving the new CEO with a lot to prove.

Intrusion Inc. ( INTZ ) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Intrusion Inc. (INTZ) settling at $1.75, representing a +1.74% change from its previous close.

Sweetgreen, Inc. ( SG ) Stock Falls Amid Market Uptick: What Investors Need to Know

In the closing of the recent trading day, Sweetgreen, Inc. (SG) stood at $8.02, denoting a -1.6% move from the preceding trading day.

Falco Announces Bought Deal Private Placement for Gross Proceeds of $10 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ...

AppFolio ( APPF ) Exceeds Market Returns: Some Facts to Consider

AppFolio (APPF) reached $282.61 at the closing of the latest trading day, reflecting a +1.46% change compared to its last close.

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Tokyo, Japan and Cambridge and London, UK, 30 September 2025 - Nxera Pharma Co., Ltd. ( "Nxera" or "the Company". TSE 4565 ) announces that it has reached a second important R&D milestone under its multi-target discovery collaboration with AbbVie focused on neurological diseases, resulting in a ...